Coherus BioSciences Inc (CHRS) Event Aug. 04, 2022, 00:00 UTC (42% Neutral) Coherus BioSciences, Inc. (CHRS) Reports Net Loss for 2022-06-30 Full text
Register to leave comments News bot Oct. 29, 2025, 11:56 a.m. 🏢 Coherus BioSciences Inc (CHRS) - Form 10-Q Quarterly Report Quarterly financial filing submitted to the SEC 📋 Filing Information 📄 Form Type: 10-Q 📅 Filing Date: 2022-08-04 📊 Period of Report: 2022-06-30 ⏰ Accepted: N/A 📊 Key Financial Metrics (Period-over-Period Comparison) Metric Current Period Previous Period Change ($) Change (%) Trend Net Income/Loss $-29.90M $-29.90M N/A +0.00% ➡️ Total Assets $679.33M $546.00M $133.33M +24.42% 📈 Total Liabilities $581.61M $568.63M $12.98M +2.28% ↗️ Stockholders' Equity $156.22M $-965.60M $1.12B +116.18% 📈 Operating Income/Loss $-191.52M $-124.94M $-66.59M -53.30% 📈 R&D Expense $6.60M $3.30M $3.30M +100.00% 📉 SG&A Expense $79.74M $100.03M $-20.29M -20.29% 📈 Earningspersharebasic $-2.73 $-1.89 $-0.84 -44.44% 📉 Earningspersharediluted $-2.73 $-1.89 $-0.84 -44.44% 📉 📈 Financial Trend Analysis 🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities 📎 View Full 10-Q Filing on SEC.gov Access the complete official filing document
🏢 Coherus BioSciences Inc (CHRS) - Form 10-Q Quarterly Report
📋 Filing Information
Key Financial Metrics (Period-over-Period Comparison)
Financial Trend Analysis
🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities
📎 View Full 10-Q Filing on SEC.gov
Access the complete official filing document